Chang Wook Kim
Overview
Explore the profile of Chang Wook Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Yim H, Seo Y, Kim J, Kim W, Jung Y, Jang J, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39828249
Background/aims: Besifovir (BSV) showed comparable antiviral activity superior safety profiles to tenofovir disoproxil fumarate (TDF) in treatment-naïve chronic hepatitis B (CHB). However, no data are available regarding the antiviral efficacy...
3.
Song D, Yang J, Jung Y, Yim H, Kim H, Kim C, et al.
Ann Hepatol
. 2024 Dec;
30(1):101749.
PMID: 39662593
Introduction And Objectives: The short-term mortality of severe alcoholic-associated hepatitis (SAH) is high, but there are no effective treatments to improve short-term mortality other than corticosteroids. This study investigated the...
4.
Sakhrekar R, Ha J, Han H, Kim D, Kim C, Kulkarni S
J Orthop Case Rep
. 2024 Sep;
14(9):220-225.
PMID: 39253681
Introduction: Os-odontoideum is a rare condition described radiographically and clinically as a congenital anomaly of the second cervical vertebra (axis). It is a smooth, independent ossicle of variable size and...
5.
Nam H, Lee J, Han J, Lee S, Yang H, Lee H, et al.
Liver Cancer
. 2024 Aug;
13(4):413-425.
PMID: 39114756
Introduction: Despite the emergence of atezolizumab and bevacizumab (A + B) as standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC), a comprehensive understanding of the clinical significance of immune-related...
6.
Yang K, Yang H, Kim C, Nam H, Kim J, Lee A, et al.
Gut Liver
. 2024 Jul;
18(5):877-887.
PMID: 39021227
Background/aims: Bile duct invasion (BDI) is rarely observed in patients with advanced hepatocellular carcinoma (HCC), leading to hyperbilirubinemia. However, the efficacy of pretreatment biliary drainage for HCC patients with BDI...
7.
Nam H, Han J, Lee S, Yang H, Lee H, Sung P, et al.
J Gastroenterol Hepatol
. 2024 May;
39(8):1673-1683.
PMID: 38690711
Background And Aim: Our study evaluated the outcomes of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in patients with chronic hepatitis B (CHB). We assessed viral and...
8.
Ha J, Sakhrekar R, Han H, Kim D, Kim C, Kulkarni S
J Orthop Case Rep
. 2024 Apr;
14(3):187-193.
PMID: 38560312
Introduction: Extraforaminal stenosis in L5-S1, or far-out syndrome (FOS), is defined as L5 nerve compression by the transverse process (TP) of the L5 and the ala of the sacrum and...
9.
Kim J, Kim S, Nam H, Kim C, Yoo J, Han J, et al.
Cureus
. 2024 Mar;
16(2):e54206.
PMID: 38496121
Introduction: Patients with hematological diseases experience complications related to portal hypertension, including life-threatening complications such as variceal bleeding. Methods: We analyzed the prognosis of patients with hematological diseases and portal...
10.
Han J, Sung P, Yoo J, Cho H, Lee S, Yang H, et al.
Front Oncol
. 2024 Mar;
14:1372007.
PMID: 38482199
Background: Atezolizumab+bevacizumab (AB) and lenvatinib have been proposed as first-line treatment options for patients with advanced hepatocellular carcinoma (HCC), but comparative efficacy and associated factors are controversial. Materials And Methods:...